TITLE

De Novo Transcriptome Assembly (NGS) of Curcuma longa L. Rhizome Reveals Novel Transcripts Related to Anticancer and Antimalarial Terpenoids

AUTHOR(S)
Annadurai, Ramasamy S.; Neethiraj, Ramprasad; Jayakumar, Vasanthan; Damodaran, Anand C.; Rao, Sudha Narayana; Katta, Mohan A. V. S. K.; Gopinathan, Sreeja; Sarma, Santosh Prasad; Senthilkumar, Vanitha; Niranjan, Vidya; Gopinath, Ashok; Mugasimangalam, Raja C.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Herbal remedies are increasingly being recognised in recent years as alternative medicine for a number of diseases including cancer. Curcuma longa L., commonly known as turmeric is used as a culinary spice in India and in many Asian countries has been attributed to lower incidences of gastrointestinal cancers. Curcumin, a secondary metabolite isolated from the rhizomes of this plant has been shown to have significant anticancer properties, in addition to antimalarial and antioxidant effects. We sequenced the transcriptome of the rhizome of the 3 varieties of Curcuma longa L. using Illumina reversible dye terminator sequencing followed by de novo transcriptome assembly. Multiple databases were used to obtain a comprehensive annotation and the transcripts were functionally classified using GO, KOG and PlantCyc. Special emphasis was given for annotating the secondary metabolite pathways and terpenoid biosynthesis pathways. We report for the first time, the presence of transcripts related to biosynthetic pathways of several anti-cancer compounds like taxol, curcumin, and vinblastine in addition to anti-malarial compounds like artemisinin and acridone alkaloids, emphasizing turmeric's importance as a highly potent phytochemical. Our data not only provides molecular signatures for several terpenoids but also a comprehensive molecular resource for facilitating deeper insights into the transcriptome of C. longa.
ACCESSION #
87624396

 

Related Articles

  • An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells. Dimas, Konstantinos; Tsimplouli, Chrisiida; Houchen, Courtney; Pantazis, Panayotis; Sakellaridis, Nikos; Tsangaris, George Th.; Anastasiadou, Ema; Ramanujam, Rama P. // Alternative Therapies in Health & Medicine;2015 Supplement 2, Vol. 21 Issue S2, p46 

    Context • Turmeric (Curcuma longa) is a food spice and colorant reported to be beneficial for human health. Curcumin (diferuloylmethane) is the major ingredient in turmeric, and existing data suggest that the spice, in combination with chemotherapy, provides a superior strategy for...

  • Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer. Zhao, Yu; Li, Chenglong; Wang, Ming; Su, Liping; Qu, Ying; Li, Jianfang; Yu, Beiqin; Yan, Min; Yu, Yingyan; Liu, Bingya; Zhu, Zhenggang // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Emerging studies have indicated that microRNAs are involved in the development and progression of cancer. Here we found that miR-202-3p was frequently down-regulated in gastric cancer tissues. Overexpression of miR-202-3p in gastric cancer cells MKN-28 and BGC-823, markedly suppressed cell...

  • How to manage mantle cell lymphoma. Dreyling, M; Ferrero, S; Hermine, O // Leukemia (08876924);Nov2014, Vol. 28 Issue 11, p2117 

    Mantle cell lymphoma (MCL) is no longer a hopeless disease. Considered to carry a uniformly dismal prognosis so far, during the last years it has been rediscovered as a heterogeneous clinical and biological entity. Such a complexity has been highlighted by molecular genetics, unraveling...

  • Herbivory-induced volatiles elicit defence genes in lima bean leaves. Arimura, Gen-ichiro; Ozawa, Rika; Shimoda, Takeshi; Nishioka, Takaaki; Boland, Wilhelm; Takabayashi, Junji // Nature;8/3/2000, Vol. 406 Issue 6795, p512 

    Discusses herbivory-induced volatiles which elicit defense genes in lima bean leaves infested with Tetranychus urticae, or spider mites. Responsibility of three terpenoids in the volatiles for the gene activation; Requirement of calcium influx and protein phosphorylation/dephosphorylation for...

  • Curcumin to Be Tried in Colon Cancer Patients. Dye, D. // Life Extension;Aug2012, p21 

    The article reports on research which will be conducted by the organization Cancer Research UK and the National Institute for Health Research Experimental Cancer Medicine Centre in an effort to investigate the use of the compound curcumin as an adjuvant treatment for colon cancer.

  • G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Tahara, Eiji; Tahara, Hidetoshi; Kanno, Masamoto; Naka, Kazuhito; Takeda, Yayoi; Matsuzaki, Takeshi; Yamazaki, Ryuta; Ishihara, Hiroto; Yasui, Wataru; Barrett, J; Ide, Toshinori; Tahara, Eiichi // Cancer Immunology, Immunotherapy;Aug2005, Vol. 54 Issue 8, p729 

    Expression of an interferon inducible gene 6-16, G1P3, increases not only in type I interferon-treated cells but also in human senescent fibroblasts. However, the function of 6-16 protein is unknown. Here we report that 6-16 is 34 kDa glycosylated protein and localized at mitochondria....

  • Proteasome Inhibitors Block Ras/ERK Signaling Pathway Resulting in the Downregulation of Fas Ligand Expression during Activation-Induced Cell Death in T Cells1. Tanimoto, Yutaka; Kizaki, Harutoshi // Journal of Biochemistry;2002, Vol. 131 Issue 3, p319 

    Activation-induced cell death (AICD) plays a critical role in the maintenance of homeostasis and peripheral tolerance in the immune system, and is mediated by Fas ligand (FasL) expression and the interaction between Fas and FasL. In the present study, we examined the role of the...

  • AACR Roundup.  // BioWorld Today;4/21/2009, Vol. 20 Issue 75, p8 

    This article looks at the results obtained by Epistem PLC from its plucked hair biomarker study which aims to determine the specific response to oral administration of Erlotinib. The study also tracked gene expression and molecular pathway change. Results of the study raises the possibility of...

  • BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer. Jiao, Shiping; Wu, Minqing; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and breast cancer models. Howerver, the antitumor activity of BikDD in triple-negative breast cancer (TNBC) is unknown. Here we show that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics